Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

[Cognitive disorders and some particularly of brain electrical activity in the use of cannabinoids].

Larionova EV.

Zh Vyssh Nerv Deiat Im I P Pavlova. 2013 Nov-Dec;63(6):643-55. Review. Russian.

PMID:
25464755
2.

It's All in the Rhythm: The Role of Cannabinoids in Neural Oscillations and Psychosis.

Skosnik PD, Cortes-Briones JA, Hajós M.

Biol Psychiatry. 2016 Apr 1;79(7):568-77. doi: 10.1016/j.biopsych.2015.12.011. Epub 2015 Dec 19. Review.

PMID:
26850792
3.

Cannabis, cannabinoids and schizophrenia: integration of the evidence.

Cohen M, Solowij N, Carr V.

Aust N Z J Psychiatry. 2008 May;42(5):357-68. doi: 10.1080/00048670801961156. Review.

PMID:
18473254
4.

Cannabis and the brain.

Iversen L.

Brain. 2003 Jun;126(Pt 6):1252-70. Review.

PMID:
12764049
5.

Cannabinoids and atherosclerosis.

Fisar Z.

Prague Med Rep. 2009;110(1):5-12. Review.

PMID:
19591373
6.

Cannabinoids and prefrontal cortical function: insights from preclinical studies.

Egerton A, Allison C, Brett RR, Pratt JA.

Neurosci Biobehav Rev. 2006;30(5):680-95. Epub 2006 Mar 29. Review.

PMID:
16574226
7.

Cannabinoids: potential targets for bladder dysfunction.

Ruggieri MR Sr.

Handb Exp Pharmacol. 2011;(202):425-51. doi: 10.1007/978-3-642-16499-6_20. Review.

PMID:
21290238
8.

Phytocannabinoids and endocannabinoids.

Fisar Z.

Curr Drug Abuse Rev. 2009 Jan;2(1):51-75. Review.

PMID:
19630737
9.

Cannabis and cannabinoid receptors.

Nocerino E, Amato M, Izzo AA.

Fitoterapia. 2000 Aug;71 Suppl 1:S6-12. Review.

PMID:
10930707
10.

The endocannabinoid system: A new player in the neurochemical control of vestibular function?

Smith PF, Ashton JC, Darlington CL.

Audiol Neurootol. 2006;11(4):207-12. Epub 2006 Apr 5. Review.

PMID:
16601324
11.

The role of cannabinoid system on immune modulation: therapeutic implications on CNS inflammation.

Correa F, Mestre L, Molina-Holgado E, Arévalo-Martín A, Docagne F, Romero E, Molina-Holgado F, Borrell J, Guaza C.

Mini Rev Med Chem. 2005 Jul;5(7):671-5. Review.

PMID:
16026313
12.

Endocannabinoid system dysfunction in mood and related disorders.

Ashton CH, Moore PB.

Acta Psychiatr Scand. 2011 Oct;124(4):250-61. doi: 10.1111/j.1600-0447.2011.01687.x. Epub 2011 Mar 9. Review.

PMID:
21916860
13.

A review of brain oscillations in cognitive disorders and the role of neurotransmitters.

Başar E, Güntekin B.

Brain Res. 2008 Oct 15;1235:172-93. doi: 10.1016/j.brainres.2008.06.103. Epub 2008 Jul 2. Review.

PMID:
18640103
14.

Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications.

Onaivi ES.

Int Rev Neurobiol. 2009;88:335-69. doi: 10.1016/S0074-7742(09)88012-4. Review.

PMID:
19897083
15.

Cannabinoid system as a potential target for drug development in the treatment of cardiovascular disease.

Mendizábal VE, Adler-Graschinsky E.

Curr Vasc Pharmacol. 2003 Oct;1(3):301-13. Review.

PMID:
15320476
16.

Mechanisms contributing to cognitive deficits in cannabis users.

Mizrahi R, Watts JJ, Tseng KY.

Neuropharmacology. 2017 Sep 15;124:84-88. doi: 10.1016/j.neuropharm.2017.04.018. Epub 2017 Apr 14. Review.

17.

The safety of cannabinoids for the treatment of multiple sclerosis.

Smith PF.

Expert Opin Drug Saf. 2005 May;4(3):443-56. Review.

PMID:
15934852
18.

Neurochemical basis of cannabis addiction.

Maldonado R, Berrendero F, Ozaita A, Robledo P.

Neuroscience. 2011 May 5;181:1-17. doi: 10.1016/j.neuroscience.2011.02.035. Epub 2011 Feb 18. Review.

PMID:
21334423
19.

Cellular approaches to the interaction between cannabinoid receptor ligands and nicotinic acetylcholine receptors.

Oz M, Al Kury L, Keun-Hang SY, Mahgoub M, Galadari S.

Eur J Pharmacol. 2014 May 15;731:100-5. doi: 10.1016/j.ejphar.2014.03.010. Epub 2014 Mar 16. Review.

PMID:
24642359
20.

Cannabis and psychiatric disorders: it is not only addiction.

Leweke FM, Koethe D.

Addict Biol. 2008 Jun;13(2):264-75. doi: 10.1111/j.1369-1600.2008.00106.x. Review.

PMID:
18482435

Supplemental Content

Support Center